Predictions
Sarepta Therapeutics
Start price
Target price
Perf. (%)
€122.15
29.10.23
29.10.23
€150.00
31.03.26
31.03.26
-
30.10.23
30.10.23
Could be very worthwhile Investment >20% year
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€7.68
23.10.23
23.10.23
-
23.10.24
23.10.24
10.16%
06.11.23
06.11.23
Top 10 in its market
Future proof or reliable business model
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€568.50
11.10.23
11.10.23
€558.00
11.10.24
11.10.24
-7.48%
14.12.23
14.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€33.12
11.10.23
11.10.23
-
11.10.24
11.10.24
14.79%
12.12.23
12.12.23
Known brand
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€24.83
11.10.23
11.10.23
-
11.10.24
11.10.24
8.30%
15.11.23
15.11.23
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€32.22
11.10.23
11.10.23
-
11.10.24
11.10.24
0.74%
14.10.23
14.10.23
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€38.99
04.10.23
04.10.23
€22.00
04.10.24
04.10.24
-16.75%
14.10.23
14.10.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€226.00
30.09.23
30.09.23
-
30.09.24
30.09.24
-15.49%
14.10.23
14.10.23
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€533.50
19.09.23
19.09.23
€558.00
19.09.24
19.09.24
6.56%
11.10.23
11.10.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€555.50
15.09.23
15.09.23
€558.00
15.09.24
15.09.24
-3.96%
19.09.23
19.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€29.39
25.08.23
25.08.23
-
25.08.24
25.08.24
0.20%
02.09.23
02.09.23